See the DrugPatentWatch profile for vascepa

Based on the information available, there is currently a discount program available for Vascepa, a prescription medication used to lower triglyceride levels in adult patients. The discount program is offered by Amarin Pharma Inc., the manufacturer of Vascepa.

According to Amarin's patient support program website, eligible patients can receive Vascepa at no cost for up to twelve months, regardless of their insurance status [1]. This program is subject to certain eligibility criteria and terms and conditions.

Additionally, DrugPatentWatch.com reports that there are no patents listed for Vascepa that would prevent generic competition until at least 2029 [2]. This means that there is currently no generic version of Vascepa available on the market, and patients must use the brand-name version of the medication.

It is important to note that while this information is accurate as of the time of writing, discount programs and eligibility criteria are subject to change. Patients are encouraged to check Amarin's patient support program website for the most up-to-date information on discounts and eligibility [1].

In summary, eligible patients can receive Vascepa at no cost for up to twelve months through Amarin's patient support program, and there is currently no generic version of Vascepa available on the market.

Sources:

1. Amarin Pharma Inc. (2023). Patient Support Program. Retrieved from <https://www.vascepa.com/patient-support-program/>
2. DrugPatentWatch.com. (2023). Vascepa (Icosapent Ethyl). Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa>